Stereotaxis Inc (STXS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Stereotaxis Inc (STXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3384
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatment of arrhythmias and coronary artery disease. The Epoch solution consists of Niobe ES robotic magnetic navigation system, Odyssey information management solution and Vdrive robotic navigation system. It also offers maintenance and support services for its integrated products. The company markets its products and services through direct sales force and through strategic alliances with other companies in the US, Europe and other parts of the world. Stereotaxis is headquartered in St. Louis, Missouri, the US.

Stereotaxis Inc (STXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stereotaxis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Stereotaxis Inc, Medical Devices Deals, 2012 to YTD 2018 9
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 11
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 12
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 13
Stereotaxis Completes Private Placement Of Shares For US$10 Million 14
Stereotaxis Inc – Key Competitors 15
Stereotaxis Inc – Key Employees 16
Stereotaxis Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Aug 07, 2018: Stereotaxis reports 2018 second quarter financial results 18
Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 20
Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 22
Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 23
Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 25
May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 26
Corporate Communications 27
Jun 04, 2018: Stereotaxis Announces Changes to its Board of Directors 27
Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Stereotaxis Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stereotaxis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stereotaxis Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Stereotaxis Inc, Medical Devices Deals, 2012 to YTD 2018 9
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 11
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 12
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 13
Stereotaxis Completes Private Placement Of Shares For US$10 Million 14
Stereotaxis Inc, Key Competitors 15
Stereotaxis Inc, Key Employees 16
Stereotaxis Inc, Other Locations 17
Stereotaxis Inc, Subsidiaries 17

List of Figures
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Stereotaxis Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Stereotaxis Inc (STXS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Keppel Corporation Limited:企業の戦略・SWOT・財務情報
    Keppel Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Keppel Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Memphasys Ltd (MEM):医療機器:M&Aディール及び事業提携情報
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis …
  • AxoGen Inc (AXGN)-製薬・医療分野:企業M&A・提携分析
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions for peripheral nerve injuries. The company offers AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products. It also offers clinical researc …
  • NGK Insulators Ltd (5333):企業の財務・戦略的SWOT分析
    NGK Insulators Ltd (5333) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Valaris Plc (VAL):企業の財務・戦略的SWOT分析
    Valaris Plc (VAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Career Education Corporation:企業の戦略・SWOT・財務情報
    Career Education Corporation - Strategy, SWOT and Corporate Finance Report Summary Career Education Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • TAS Energy Inc:企業の戦略的SWOT分析
    TAS Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Nordstrom Inc (JWN):企業の財務・戦略的SWOT分析
    Nordstrom Inc (JWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • JG Summit Holdings Inc:企業の戦略・SWOT・財務情報
    JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Physiomics Plc (PYC):企業の財務・戦略的SWOT分析
    Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ArmorWorks Enterprises, LLC:企業の戦略・SWOT・財務情報
    ArmorWorks Enterprises, LLC - Strategy, SWOT and Corporate Finance Report Summary ArmorWorks Enterprises, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Grupa Lotos SA (LTS):企業の財務・戦略的SWOT分析
    Grupa Lotos SA (LTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kumagai Gumi Co., Ltd.:企業の戦略・SWOT・財務分析
    Kumagai Gumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kumagai Gumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cellmid Ltd (CDY):医療機器:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Bharat Road Network Limited (BRNL):企業の財務・戦略的SWOT分析
    Bharat Road Network Limited (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Esprit Holdings Limited
    Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Zimplats Holdings Ltd:企業の戦略・SWOT・財務情報
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Savara Inc (SVRA):企業の財務・戦略的SWOT分析
    Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nexgenia Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nexgenia Inc (Nexgenia) is a developer and manufacturer of proprietary polymer-based reagents. The company offers stimuli-responsive polymers and polymer-containing magnetic nanoparticles that develops speed, efficiency and sensitivity of molecular and cell separations for diagnostic and lif …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆